Abstract
BACKGROUND: The psychopathological syndrome of formal thought disorder (FTD) is present in schizophrenia (SZ) but is also highly prevalent in major depression (MDD) and bipolar disorder (BD). It remains unknown how alterations in the structural white matter connectome of the brain correlate with psychopathological FTD dimensions across affective and psychotic disorders.
METHODS: Using FTD items of the SAPS and SANS, we performed exploratory and confirmatory factor analyses in N=864 patients with MDD (n=689), BD (n=108) or SZ (n=67) to identify psychopathological FTD dimensions. We used T1 and diffusion-weighted magnetic resonance imaging to reconstruct the structural connectome of the brain. To investigate the association of FTD sub-dimensions and global structural connectome measures, we employed linear regression models. We used network-based statistic (NBS) to identify subnetworks of white matter fiber tracts associated with FTD symptomatology.
RESULTS: Three psychopathological FTD dimensions were delineated, i.e. disorganization, emptiness, and incoherence. "Disorganization" and "incoherence" were associated with global dysconnectivity. NBS identified subnetworks associated with FTD dimensions "disorganization" and "emptiness" but not with "incoherence". Post-hoc analyses on subnetworks did not reveal diagnosis x FTD dimension interaction effects. Results remained stable after correcting for medication and disease severity. Confirmatory analyses showed a substantial overlap of nodes from both subnetworks with cortical brain regions previously associated with FTD in SZ.
CONCLUSIONS: We demonstrated white matter subnetwork dysconnectivity in MDD, BD and SZ associated with FTD dimensions that comprise predominantly brain regions implicated in speech. Results open an avenue for transdiagnostic, psychopathology informed, dimensional studies in pathogenetic research.
Original language | English |
---|---|
Pages (from-to) | 629-638 |
Number of pages | 10 |
Journal | Biological psychiatry |
Volume | 95 |
Issue number | 7 |
Early online date | 18 May 2023 |
DOIs | |
Publication status | Published - 1 Apr 2024 |
Bibliographical note
Copyright © 2023. Published by Elsevier Inc.Funding
TK has received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, and Neuraxpharm. All other authors report no biomedical financial interests or potential conflicts of interest. This work is part of the German multicentre consortium “Neurobiology of Affective Disorders. A translational perspective on brain structure and function,” funded by the German Research Foundation (Research Unit FOR2107). The principal investigators are TK (Grant Nos. KI588/14-1, KI588/14-2, KI588/20-1, KI588/22-1), UD (Grant Nos. DA1151/5-1, DA1151/5-2), AK (Grant Nos KR3822/5-1, KR3822/7-2), IN (Grant Nos. NE2254/1-2, NE2254/3-1, NE2254/4-1), and CK (Grant No. KO4291/3-1). The study was in part supported by grants from UKGM and Forschungscampus Mittelhessen to IN. SCdL was funded by ZonMw Open Competition, project REMOVE Grant No. 09120011910032. This work is part of the German multicentre consortium “Neurobiology of Affective Disorders. A translational perspective on brain structure and function,” funded by the German Research Foundation (Research Unit FOR2107). The principal investigators are TK (Grant Nos. KI588/14-1, KI588/14-2, KI588/20-1, KI588/22-1), UD (Grant Nos. DA1151/5-1, DA1151/5-2), AK (Grant Nos KR3822/5-1, KR3822/7-2), IN (Grant Nos. NE2254/1-2, NE2254/3-1, NE2254/4-1), and CK (Grant No. KO4291/3-1). The study was in part supported by grants from UKGM and Forschungscampus Mittelhessen to IN. SCdL was funded by ZonMw Open Competition, project REMOVE Grant No. 09120011910032. The FOR2107 cohort project was approved by the Ethics Committees of the Medical Faculties, University of Marburg (AZ:07/14) and University of Münster (AZ:2014-422-b-S). We are deeply indebted to all study participants and staff. A list of acknowledgments can be found online ( www.for2107.de/acknowledgements). TK has received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, and Neuraxpharm. All other authors report no biomedical financial interests or potential conflicts of interest.
Funders | Funder number |
---|---|
Forschungscampus Mittelhessen | |
ZonMw Open Competition | 09120011910032 |
Janssen Pharmaceutica | |
Philipps-Universität Marburg | AZ:07/14 |
Philipps-Universität Marburg | |
Deutsche Forschungsgemeinschaft | KI588/14-1, KO4291/3-1, DA1151/5-2, DA1151/5-1, KR3822/5-1, KR3822/7-2, FOR2107, NE2254/1-2, NE2254/3-1, NE2254/4-1, KI588/20-1, KI588/22-1, KI588/14-2 |
Deutsche Forschungsgemeinschaft | |
Westfälische Wilhelms-Universität Münster | AZ:2014-422-b-S |
Westfälische Wilhelms-Universität Münster | |
Uniklinikum Giessen und Marburg | |
Servier |